Literature DB >> 33756424

Coinfection of porcine deltacoronavirus and porcine epidemic diarrhea virus altered viral tropism in gastrointestinal tract in a piglet model.

Zhe Jiao1, Jixiang Liang2, Yilin Yang1, Yang Li2, Zhishan Yan2, Guangli Hu1, Changqin Gu2, Xueying Hu2, Guofu Cheng2, Guiqing Peng3, Wanpo Zhang4.   

Abstract

Coinfection of porcine epidemic diarrhea virus (PEDV) and porcine deltacoronavirus (PDCoV) is one of common findings in diarrheal piglets that cause massive economic losses to the pig industry globally. However, the mechanism of the co-infection is unclear. In this study, neonatal non-colostrum-fed piglets were exposed orally with a single infection of PDCoV or PEDV, or coinfection of PDCoV and PEDV. Clinically all viral infected piglets developed watery diarrhea and dehydration in 24 h post-exposure (hpe) and were succumbed to viral diarrhea disease and euthanized at 72 hpe. Histopathologically, acute gastroenteritis is evident in all viral infected piglet. Immunohistochemistry, RNAscope and RT-qPCR demonstrated that PEDV tropism changes from epithelial cells of small intestine to gastric epithelial cells and macrophages in Peyer's patches in the ileum. These findings suggest that coinfection of PDCoV and PEDV can alter PEDV tropism that may affect the outcome of viral disease in piglets. This animal model can be used for the pathogenesis and vaccination of viral coinfection in piglet in the future.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Coinfection; Piglets; Porcine deltacoronavirus; Porcine epidemic diarrhea virus; Viral localization

Mesh:

Year:  2021        PMID: 33756424     DOI: 10.1016/j.virol.2021.03.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  1 in total

1.  Study of the effect of intestinal immunity in neonatal piglets coinfected with porcine deltacoronavirus and porcine epidemic diarrhea virus.

Authors:  Jixiang Liang; Yang Li; Zhishan Yan; Zhe Jiao; Dapeng Peng; Wanpo Zhang
Journal:  Arch Virol       Date:  2022-06-04       Impact factor: 2.685

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.